table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Lung Cancer Molecular Diagnostics Market Size Analysis from 2022 to 2027
1.5.1 Global Lung Cancer Molecular Diagnostics Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Lung Cancer Molecular Diagnostics Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Lung Cancer Molecular Diagnostics Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Lung Cancer Molecular Diagnostics Industry Impact
Chapter 2 Global Lung Cancer Molecular Diagnostics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Lung Cancer Molecular Diagnostics (Volume and Value) by Type
2.1.1 Global Lung Cancer Molecular Diagnostics Consumption and Market Share by Type (2016-2021)
2.1.2 Global Lung Cancer Molecular Diagnostics Revenue and Market Share by Type (2016-2021)
2.2 Global Lung Cancer Molecular Diagnostics (Volume and Value) by Application
2.2.1 Global Lung Cancer Molecular Diagnostics Consumption and Market Share by Application (2016-2021)
2.2.2 Global Lung Cancer Molecular Diagnostics Revenue and Market Share by Application (2016-2021)
2.3 Global Lung Cancer Molecular Diagnostics (Volume and Value) by Regions
2.3.1 Global Lung Cancer Molecular Diagnostics Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Lung Cancer Molecular Diagnostics Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Lung Cancer Molecular Diagnostics Consumption by Regions (2016-2021)
4.2 North America Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
4.10 South America Lung Cancer Molecular Diagnostics Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Lung Cancer Molecular Diagnostics Market Analysis
5.1 North America Lung Cancer Molecular Diagnostics Consumption and Value Analysis
5.1.1 North America Lung Cancer Molecular Diagnostics Market Under COVID-19
5.2 North America Lung Cancer Molecular Diagnostics Consumption Volume by Types
5.3 North America Lung Cancer Molecular Diagnostics Consumption Structure by Application
5.4 North America Lung Cancer Molecular Diagnostics Consumption by Top Countries
5.4.1 United States Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
5.4.2 Canada Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
5.4.3 Mexico Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 6 East Asia Lung Cancer Molecular Diagnostics Market Analysis
6.1 East Asia Lung Cancer Molecular Diagnostics Consumption and Value Analysis
6.1.1 East Asia Lung Cancer Molecular Diagnostics Market Under COVID-19
6.2 East Asia Lung Cancer Molecular Diagnostics Consumption Volume by Types
6.3 East Asia Lung Cancer Molecular Diagnostics Consumption Structure by Application
6.4 East Asia Lung Cancer Molecular Diagnostics Consumption by Top Countries
6.4.1 China Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
6.4.2 Japan Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
6.4.3 South Korea Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 7 Europe Lung Cancer Molecular Diagnostics Market Analysis
7.1 Europe Lung Cancer Molecular Diagnostics Consumption and Value Analysis
7.1.1 Europe Lung Cancer Molecular Diagnostics Market Under COVID-19
7.2 Europe Lung Cancer Molecular Diagnostics Consumption Volume by Types
7.3 Europe Lung Cancer Molecular Diagnostics Consumption Structure by Application
7.4 Europe Lung Cancer Molecular Diagnostics Consumption by Top Countries
7.4.1 Germany Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.2 UK Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.3 France Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.4 Italy Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.5 Russia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.6 Spain Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.7 Netherlands Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.8 Switzerland Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
7.4.9 Poland Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 8 South Asia Lung Cancer Molecular Diagnostics Market Analysis
8.1 South Asia Lung Cancer Molecular Diagnostics Consumption and Value Analysis
8.1.1 South Asia Lung Cancer Molecular Diagnostics Market Under COVID-19
8.2 South Asia Lung Cancer Molecular Diagnostics Consumption Volume by Types
8.3 South Asia Lung Cancer Molecular Diagnostics Consumption Structure by Application
8.4 South Asia Lung Cancer Molecular Diagnostics Consumption by Top Countries
8.4.1 India Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
8.4.2 Pakistan Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Lung Cancer Molecular Diagnostics Market Analysis
9.1 Southeast Asia Lung Cancer Molecular Diagnostics Consumption and Value Analysis
9.1.1 Southeast Asia Lung Cancer Molecular Diagnostics Market Under COVID-19
9.2 Southeast Asia Lung Cancer Molecular Diagnostics Consumption Volume by Types
9.3 Southeast Asia Lung Cancer Molecular Diagnostics Consumption Structure by Application
9.4 Southeast Asia Lung Cancer Molecular Diagnostics Consumption by Top Countries
9.4.1 Indonesia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.2 Thailand Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.3 Singapore Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.4 Malaysia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.5 Philippines Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.6 Vietnam Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
9.4.7 Myanmar Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 10 Middle East Lung Cancer Molecular Diagnostics Market Analysis
10.1 Middle East Lung Cancer Molecular Diagnostics Consumption and Value Analysis
10.1.1 Middle East Lung Cancer Molecular Diagnostics Market Under COVID-19
10.2 Middle East Lung Cancer Molecular Diagnostics Consumption Volume by Types
10.3 Middle East Lung Cancer Molecular Diagnostics Consumption Structure by Application
10.4 Middle East Lung Cancer Molecular Diagnostics Consumption by Top Countries
10.4.1 Turkey Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.3 Iran Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.5 Israel Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.6 Iraq Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.7 Qatar Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.8 Kuwait Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
10.4.9 Oman Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 11 Africa Lung Cancer Molecular Diagnostics Market Analysis
11.1 Africa Lung Cancer Molecular Diagnostics Consumption and Value Analysis
11.1.1 Africa Lung Cancer Molecular Diagnostics Market Under COVID-19
11.2 Africa Lung Cancer Molecular Diagnostics Consumption Volume by Types
11.3 Africa Lung Cancer Molecular Diagnostics Consumption Structure by Application
11.4 Africa Lung Cancer Molecular Diagnostics Consumption by Top Countries
11.4.1 Nigeria Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.2 South Africa Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.3 Egypt Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.4 Algeria Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
11.4.5 Morocco Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 12 Oceania Lung Cancer Molecular Diagnostics Market Analysis
12.1 Oceania Lung Cancer Molecular Diagnostics Consumption and Value Analysis
12.2 Oceania Lung Cancer Molecular Diagnostics Consumption Volume by Types
12.3 Oceania Lung Cancer Molecular Diagnostics Consumption Structure by Application
12.4 Oceania Lung Cancer Molecular Diagnostics Consumption by Top Countries
12.4.1 Australia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
12.4.2 New Zealand Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 13 South America Lung Cancer Molecular Diagnostics Market Analysis
13.1 South America Lung Cancer Molecular Diagnostics Consumption and Value Analysis
13.1.1 South America Lung Cancer Molecular Diagnostics Market Under COVID-19
13.2 South America Lung Cancer Molecular Diagnostics Consumption Volume by Types
13.3 South America Lung Cancer Molecular Diagnostics Consumption Structure by Application
13.4 South America Lung Cancer Molecular Diagnostics Consumption Volume by Major Countries
13.4.1 Brazil Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.2 Argentina Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.3 Columbia Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.4 Chile Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.5 Venezuela Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.6 Peru Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
13.4.8 Ecuador Lung Cancer Molecular Diagnostics Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Lung Cancer Molecular Diagnostics Business
14.1 Foundationmedicine
14.1.1 Foundationmedicine Company Profile
14.1.2 Foundationmedicine Lung Cancer Molecular Diagnostics Product Specification
14.1.3 Foundationmedicine Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Sansure
14.2.1 Sansure Company Profile
14.2.2 Sansure Lung Cancer Molecular Diagnostics Product Specification
14.2.3 Sansure Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Liferiver
14.3.1 Liferiver Company Profile
14.3.2 Liferiver Lung Cancer Molecular Diagnostics Product Specification
14.3.3 Liferiver Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Roche
14.4.1 Roche Company Profile
14.4.2 Roche Lung Cancer Molecular Diagnostics Product Specification
14.4.3 Roche Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Gpmedical
14.5.1 Gpmedical Company Profile
14.5.2 Gpmedical Lung Cancer Molecular Diagnostics Product Specification
14.5.3 Gpmedical Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Qiagen
14.6.1 Qiagen Company Profile
14.6.2 Qiagen Lung Cancer Molecular Diagnostics Product Specification
14.6.3 Qiagen Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Mole
14.7.1 Mole Company Profile
14.7.2 Mole Lung Cancer Molecular Diagnostics Product Specification
14.7.3 Mole Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Genetech
14.8.1 Genetech Company Profile
14.8.2 Genetech Lung Cancer Molecular Diagnostics Product Specification
14.8.3 Genetech Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Tellgen
14.9.1 Tellgen Company Profile
14.9.2 Tellgen Lung Cancer Molecular Diagnostics Product Specification
14.9.3 Tellgen Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Amoydx
14.10.1 Amoydx Company Profile
14.10.2 Amoydx Lung Cancer Molecular Diagnostics Product Specification
14.10.3 Amoydx Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Annoroad
14.11.1 Annoroad Company Profile
14.11.2 Annoroad Lung Cancer Molecular Diagnostics Product Specification
14.11.3 Annoroad Lung Cancer Molecular Diagnostics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Lung Cancer Molecular Diagnostics Market Forecast (2022-2027)
15.1 Global Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Lung Cancer Molecular Diagnostics Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Lung Cancer Molecular Diagnostics Value and Growth Rate Forecast (2022-2027)
15.2 Global Lung Cancer Molecular Diagnostics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Lung Cancer Molecular Diagnostics Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Lung Cancer Molecular Diagnostics Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Lung Cancer Molecular Diagnostics Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Lung Cancer Molecular Diagnostics Consumption Forecast by Type (2022-2027)
15.3.2 Global Lung Cancer Molecular Diagnostics Revenue Forecast by Type (2022-2027)
15.3.3 Global Lung Cancer Molecular Diagnostics Price Forecast by Type (2022-2027)
15.4 Global Lung Cancer Molecular Diagnostics Consumption Volume Forecast by Application (2022-2027)
15.5 Lung Cancer Molecular Diagnostics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
